UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 22 filers reported holding UROVANT SCIENCES LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,309,000 | -24.3% | 568,436 | -20.2% | 0.00% | 0.0% |
| Q2 2020 | $7,013,000 | -14.9% | 712,736 | -20.2% | 0.00% | 0.0% |
| Q1 2020 | $8,238,000 | -49.7% | 893,536 | -15.5% | 0.00% | -50.0% |
| Q4 2019 | $16,393,000 | +1.2% | 1,056,936 | -38.2% | 0.00% | 0.0% |
| Q3 2019 | $16,202,000 | +19.7% | 1,710,836 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,533,000 | -21.3% | 1,710,836 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $17,194,000 | +95.8% | 1,710,836 | +28.4% | 0.00% | +100.0% |
| Q4 2018 | $8,782,000 | -39.0% | 1,332,701 | +11.1% | 0.00% | -50.0% |
| Q3 2018 | $14,400,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|